US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 2.1600
- +0.0100+0.47%
Close Nov 1 16:00 ET
- 2.1600
- 0.00000.00%
Post 20:02 ET
13.17MMarket Cap-831P/E (TTM)
2.2461High2.0400Low31.61KVolume2.2000Open2.1500Pre Close67.89KTurnover0.52%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High5.31P/B13.17MFloat Cap1.830052wk Low--Dividend TTM6.10MShs Float1419.0000Historical High--Div YieldTTM9.59%Amplitude1.5200Historical Low2.1470Avg Price1Lot Size
Can-Fite BioPharma Key Stats
EPS
According to the latest financial report of Can-Fite BioPharma, the latest earnings per share (TTM) for the company is -1.52. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Can-Fite BioPharma's free cash flow? The latest report shows it as -2.81M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Can-Fite BioPharma shows that the company's current ratio is 2.93, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Can-Fite BioPharma, the quick ratio is 2.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Can-Fite BioPharma? The latest ROE figure is -28.79%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Can-Fite BioPharma, the total asset return on investment (ROA) is -17.25%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Can-Fite BioPharma's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Can-Fite BioPharma, the net profit margin is -1.07K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data